Drug:
Reaction: DERMATITIS ATOPIC
20260101 - 20261231
No. 1401 - 1500
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1401 | 26783421 |
US |
54 | 2 |
Blister, Skin burning sensation, Dermatitis atopic, |
||||
DUPILUMAB, NEMOLIZUMAB-ILTO, |
||||
| 1402 | 26783427 |
US |
4 | 2 |
Eye allergy, Dermatitis atopic, Product dose omission issue, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 1403 | 26783663 |
US |
71 | 2 |
Dermatitis atopic, Psoriasis, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1404 | 26783686 |
US |
46 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1405 | 26783950 |
US |
63 | 2 |
Stress, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1406 | 26783968 |
US |
11 | 1 |
Seasonal allergy, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1407 | 26784003 |
US |
54 | 2 |
Dermatitis atopic, Rash erythematous, Pruritus, Skin burning sensation, |
||||
DUPILUMAB, |
||||
| 1408 | 26784016 |
US |
9 | 2 |
Dermatitis atopic, Sleep disorder due to a general medical condition, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 1409 | 26784418 |
US |
15 | 2 |
Dermatitis atopic, Therapeutic response decreased, |
||||
DUPILUMAB, |
||||
| 1410 | 26784425 |
US |
1 | |
Scratch, Dermatitis atopic, |
||||
DUPILUMAB, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, ACETAMINOPHEN, ASPIRIN, CAFFEINE, |
||||
| 1411 | 26784436 |
US |
52 | 2 |
Dermatitis atopic, Erythema, Pruritus, Skin warm, |
||||
DUPILUMAB, |
||||
| 1412 | 26784455 |
US |
30 | 2 |
Pruritus, Skin haemorrhage, Skin weeping, Skin fissures, Dry skin, Skin exfoliation, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1413 | 26784487 |
US |
61 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1414 | 26784521 |
US |
6 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1415 | 26784806 |
US |
78 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1416 | 26784807 |
US |
5 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1417 | 26784837 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1418 | 26784853 |
US |
2 | |
Dermatitis atopic, Inappropriate schedule of product administration, Stress, |
||||
DUPILUMAB, |
||||
| 1419 | 26784862 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1420 | 26785182 |
US |
37 | 2 |
Rash erythematous, Pruritus, Skin burning sensation, Dermatitis atopic, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 1421 | 26785190 |
US |
31 | 1 |
Dermatitis atopic, Rash erythematous, |
||||
DUPILUMAB, |
||||
| 1422 | 26785197 |
US |
68 | 1 |
Dermatitis atopic, Dry skin, Erythema, |
||||
DUPILUMAB, |
||||
| 1423 | 26785217 |
US |
8 | 2 |
Dermatitis atopic, Dry skin, Pruritus, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 1424 | 26785227 |
US |
52 | 2 |
Sleep disorder, Injection site swelling, Injection site pain, Injection site pruritus, Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, DIPHENHYDRAMINE HYDROCHLORIDE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, IPRATROPIUM BROMIDE AND ALBUTEROL, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, ACETAMINOPHEN, ASPIRIN, AND CAFFEINE, FISH OIL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, MONTELUKAST SODIUM, MONTELUKAST, NAPROXEN SODIUM, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, GUAIFENESIN, NAPROXEN SODIUM, PSEUDOEPHEDRINE HYDROCHLORIDE, PRAVASTATIN SODIUM, TOPIRAMATE, ERGOCALCIFEROL, CARBAMAZEPINE, RIMEGEPANT SULFATE, |
||||
| 1425 | 26785499 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, ALBUTEROL SULFATE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, CETIRIZINE HYDROCHLORIDE, |
||||
| 1426 | 26785504 |
US |
26 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1427 | 26785512 |
US |
83 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1428 | 26786088 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, |
||||
| 1429 | 26786320 |
US |
27 | 1 |
Dermatitis atopic, Drug ineffective, |
||||
DUPILUMAB, ALBUTEROL SULFATE, ALBUTEROL, DIPHENHYDRAMINE HYDROCHLORIDE, ETODOLAC, FLUTICASONE PROPIONATE AND SALMETEROL, CETIRIZINE HYDROCHLORIDE, |
||||
| 1430 | 26786329 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1431 | 26786568 |
US |
49 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1432 | 26786578 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, CETIRIZINE HCL, CETIRIZINE, FOLIC ACID, ERGOCALCIFEROL, |
||||
| 1433 | 26786583 |
US |
31 | 1 |
Sleep disorder due to a general medical condition, Dermatitis atopic, Pruritus, Skin fissures, Skin weeping, Skin haemorrhage, Dry skin, Skin exfoliation, Therapeutic response decreased, |
||||
DUPILUMAB, |
||||
| 1434 | 26786586 |
US |
54 | 1 |
Dermatitis atopic, Drug ineffective, |
||||
DUPILUMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, BUPROPION HYDROCHLORIDE, DESVENLAFAXINE, DESVENLAFAXINE SUCCINATE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LISINOPRIL, MELOXICAM, MUPIROCIN, MUPIROCIN CALCIUM, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TIZANIDINE HYDROCHLORIDE, |
||||
| 1435 | 26786721 |
US |
4 | 2 |
Pruritus, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1436 | 26786722 |
US |
3 | 1 |
Erythema, Eye pain, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1437 | 26786811 |
US |
5 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1438 | 26786815 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1439 | 26786851 |
US |
20 | 2 |
Eyelid margin crusting, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1440 | 26787072 |
US |
2 | |
Pruritus, Sleep disorder due to a general medical condition, Dermatitis atopic, Neurodermatitis, |
||||
DUPILUMAB, DUPILUMAB, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, BUPROPION, BUSPIRONE HYDROCHLORIDE, GALCANEZUMAB-GNLM, FEXOFENADINE, BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, SUMATRIPTAN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ORAL SEMAGLUTIDE, OXYMETAZOLINE HYDROCHLORIDE, MONTELUKAST SODIUM, |
||||
| 1441 | 26787076 |
US |
56 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, AMITRIPTYLINE HYDROCHLORIDE, BIOTIN, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, GABAPENTIN, BISACODYL, MAGNESIUM HYDROXIDE, LISINOPRIL, NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL, NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL TABLETS AND FERROUS FUMARATE TABLETS, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ROSUVASTATIN CALCIUM, LEVOTHYROXINE SODIUM, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 1442 | 26776378 |
US |
82 | 2 |
Dermatitis atopic, Rash, |
||||
DUPILUMAB, |
||||
| 1443 | 26776392 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, ALPRAZOLAM, BUPROPION HYDROCHLORIDE, DEXTROAMPHETAMINE, MINOXIDIL, MINOXIDIL FOAM 5% (WOMENS), OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PIMECROLIMUS, |
||||
| 1444 | 26776397 |
US |
55 | 2 |
Dermatitis atopic, Rash, |
||||
DUPILUMAB, DUPILUMAB, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, |
||||
| 1445 | 26776513 |
US |
80 | 1 |
Dermatitis atopic, Skin lesion, Dry skin, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 1446 | 26776521 |
US |
18 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1447 | 26776538 |
US |
28 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1448 | 26776545 |
US |
21 | 1 |
Dermatitis atopic, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 1449 | 26776787 |
US |
19 | 2 |
Dermatitis atopic, |
||||
LEBRIKIZUMAB-LBKZ, |
||||
| 1450 | 26776834 |
US |
64 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1451 | 26776837 |
US |
36 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1452 | 26777075 |
US |
81 | 2 |
Dermatitis atopic, Pruritus, Sleep disorder due to a general medical condition, Product dose omission issue, Rash, |
||||
DUPILUMAB, FISH OIL, VITAMIN C, |
||||
| 1453 | 26777445 |
US |
24 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1454 | 26777453 |
US |
66 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1455 | 26777458 |
US |
52 | 1 |
Dermatitis atopic, Product dose omission in error, |
||||
DUPILUMAB, |
||||
| 1456 | 26777654 |
EU |
37 | 1 |
Dermatitis atopic, Lymphopenia, Skin exfoliation, |
||||
CYCLOSPORINE, |
||||
| 1457 | 26777668 |
US |
1 | |
Abdominal distension, Dermatitis atopic, Drug ineffective, |
||||
DUPILUMAB, BENZONATATE, BETAMETHASONE DIPROPIONATE, FLUTICASONE PROPIONATE, METHYLPREDNISOLONE, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, PREDNISONE, |
||||
| 1458 | 26778046 |
US |
59 | 2 |
Dermatitis atopic, Rash, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 1459 | 26778107 |
US |
54 | 1 |
Coma, Weight decreased, Dry skin, Skin discolouration, Erythema, Dermatitis atopic, Inflammation, Pruritus, |
||||
BUPROPION HYDROCHLORIDE, DUPILUMAB, DUPILUMAB, |
||||
| 1460 | 26778312 |
US |
3 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 1461 | 26778330 |
US |
2 | |
Dermatitis atopic, Accidental exposure to product, Exposure via skin contact, |
||||
DUPILUMAB, |
||||
| 1462 | 26778344 |
EU |
25 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1463 | 26778717 |
US |
1 | 2 |
Sleep disorder, Malaise, Infection, Dermatitis atopic, Skin exfoliation, Pruritus, Dry skin, |
||||
DUPILUMAB, |
||||
| 1464 | 26779198 |
US |
63 | 2 |
Respiratory tract congestion, Nasopharyngitis, Urticaria, Dermatitis atopic, Erythema, |
||||
DUPILUMAB, |
||||
| 1465 | 26779215 |
US |
2 | |
Dermatitis atopic, Product dose omission issue, Pruritus, |
||||
DUPILUMAB, |
||||
| 1466 | 26779567 |
US |
2 | |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1467 | 26779572 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1468 | 26779579 |
US |
68 | 1 |
Dermatitis atopic, Drug ineffective, Pustule, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1469 | 26779597 |
US |
63 | 2 |
Injection site injury, Neck pain, Back pain, Blister, Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1470 | 26779897 |
US |
1 | |
Dermatitis atopic, Rash, |
||||
DUPILUMAB, |
||||
| 1471 | 26779911 |
US |
59 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1472 | 26780273 |
US |
59 | 2 |
Atrial fibrillation, Intentional dose omission, Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1473 | 26781165 |
US |
45 | 2 |
Conjunctivitis, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1474 | 26781168 |
US |
23 | 2 |
Dermatitis atopic, Rash erythematous, Sunburn, |
||||
DUPILUMAB, |
||||
| 1475 | 26781441 |
US |
15 | 1 |
Weight decreased, Dermatitis atopic, |
||||
UPADACITINIB, UPADACITINIB, |
||||
| 1476 | 26781491 |
US |
2 | |
Hypertension, Glucose tolerance impaired, Dermatitis atopic, |
||||
DUPILUMAB, ALBUTEROL SULFATE, CETIRIZINE HCL, CETIRIZINE, ORAL SEMAGLUTIDE, SPIRONOLACTONE, SUMATRIPTAN, SUMATRIPTAN SUCCINATE, ERGOCALCIFEROL, |
||||
| 1477 | 26781613 |
US |
2 | 2 |
Dermatitis atopic, Rash, Dry skin, Pruritus, Nasopharyngitis, Therapeutic response shortened, Therapeutic response unexpected, |
||||
DUPILUMAB, CETIRIZINE HYDROCHLORIDE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, |
||||
| 1478 | 26781741 |
US |
39 | |
Dermatitis atopic, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 1479 | 26770880 |
US |
52 | 2 |
Dermatitis atopic, Rash, |
||||
DUPILUMAB, |
||||
| 1480 | 26770882 |
US |
70 | 2 |
Dermatitis atopic, Pruritus, Erythema, Rash, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1481 | 26771030 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1482 | 26771174 |
US |
43 | 2 |
Dermatitis atopic, Therapeutic response shortened, Anxiety, Therapeutic response unexpected, |
||||
DUPILUMAB, DUPILUMAB, NEMOLIZUMAB-ILTO, |
||||
| 1483 | 26771196 |
US |
50 | 2 |
Dermatitis atopic, Rash, |
||||
DUPILUMAB, |
||||
| 1484 | 26771199 |
US |
1 | |
Dermatitis atopic, Pruritus, Skin wound, Skin haemorrhage, Skin erosion, |
||||
DUPILUMAB, |
||||
| 1485 | 26771233 |
US |
22 | 1 |
Dermatitis contact, Dermatitis atopic, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1486 | 26771467 |
US |
1 | |
Dermatitis atopic, Skin irritation, |
||||
DUPILUMAB, |
||||
| 1487 | 26771470 |
US |
19 | 2 |
Miliaria, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1488 | 26771471 |
US |
29 | 2 |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1489 | 26771475 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1490 | 26771480 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1491 | 26771498 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1492 | 26771699 |
US |
||
Dermatitis atopic, |
||||
LEBRIKIZUMAB-LBKZ, |
||||
| 1493 | 26771716 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, ALBUTEROL SULFATE, AZELASTINE HYDROCHLORIDE, AZELASTINE, FLUTICASONE PROPIONATE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, METRONIDAZOLE, METRONIDAZOLE TOPICAL, MONTELUKAST SODIUM, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, CETIRIZINE HYDROCHLORIDE, |
||||
| 1494 | 26771717 |
US |
1 | |
Limb discomfort, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1495 | 26771733 |
US |
43 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1496 | 26771736 |
US |
62 | 1 |
Stress, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1497 | 26771758 |
US |
1 | |
Eczema, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1498 | 26771958 |
US |
4 | 1 |
Pruritus, Insomnia, Skin fissures, Skin haemorrhage, Dermatitis atopic, Drug ineffective, |
||||
DUPILUMAB, |
||||
| 1499 | 26771980 |
US |
2 | |
Illness, Dermatitis atopic, |
||||
DUPILUMAB, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, |
||||
| 1500 | 26772000 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30